Patent details
EP2391345 Title: Galenic formulations comprising aliskiren
Basic Information
- Publication number:
- EP2391345
- PCT Application Number:
- PCT/EP/2010/050886
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107020927
- PCT Publication Number:
- WO/2010/086312
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Galenic formulations comprising aliskiren
- French Title of Invention:
- Formulations galéniques comprenant de l'aliskiren
- German Title of Invention:
- Galenische Formulierungen enthaltend Aliskiren
- SPC Number:
Dates
- Filing date:
- 27/01/2010
- Grant date:
- 03/09/2014
- EP Publication Date:
- 03/09/2014
- PCT Publication Date:
- 05/08/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/12/2011
- EP B1 Publication Date:
- 03/09/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/01/2015
- Expiration date:
- 27/01/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/01/2010
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- DESSET-BRÈTHES Sabine
- Address:
- Switzerland (CH)
2
- Name:
- HIRSCH Stefan
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 09151496
- Priority Date:
- 28/01/2009
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 9/14;
| Filing date | Document type | Number of pages |
|---|